AbbVie has secured its fourth FDA approval for Vraylar, adding adjunctive therapy of major depressive disorder (MDD) to a list that includes schizophrenia and manic and depressive episodes in ...

For years, diagnosis of OSA has relied on complex polysomnography equipment to monitor heart, lung and brain activity, breathing patterns, limb movements, and blood oxygen levels while the patient ...